Health-Related Quality of Life and Neurocognition in Alagille Syndrome

  • Saeed MohammadEmail author
  • Estella M. Alonso


Alagille syndrome (ALGS) is a multisystem disease with variable clinical penetrance involving the liver, heart, blood vessels, kidneys, eyes, and bones. Health-related quality of life (HRQOL) in ALGS is affected by the degree and number of organ systems involved. Growth failure, jaundice, the severity of extrahepatic comorbidities (particularly cardiovascular), and mental health are all associated with lower HRQOL. Two large studies of ALGS patients have shown they have lower HRQOL compared to normal children and score lower than children with other liver diseases in specific domains as well. Data on targeted medical and surgical interventions to support functional outcomes are needed which may also improve overall HRQOL.

Data on neurocognitive outcomes, although limited, suggest a high prevalence of neurocognitive deficits which persist post transplantation. Mental health and academic development needs should be considered and assessed continuously to improve cognitive outcomes in the ALGS population. Multicenter research networks are needed to study neurocognitive outcomes in this very heterogeneous disease.


Growth failure Pruritus Executive function Liver transplantation Cholestasis IQ PedsQL™ 


  1. 1.
    Sundaram SS, et al. Health related quality of life in patients with biliary atresia surviving with their native liver. J Pediatr. 2013;163(4):1052–7. e2CrossRefGoogle Scholar
  2. 2.
    Stewart SM, et al. Mental and motor development correlates in patients with end-stage biliary atresia awaiting liver transplantation. Pediatrics. 1987;79(6):882–8.PubMedGoogle Scholar
  3. 3.
    Alonso EM, et al. Cross-sectional analysis of health-related quality of life in pediatric liver transplant recipients. J Pediatr. 2010;156(2):270–6. e1CrossRefGoogle Scholar
  4. 4.
    Wayman KI, Cox KL, Esquivel CO. Neurodevelopmental outcome of young children with extrahepatic biliary atresia 1 year after liver transplantation. J Pediatr. 1997;131(6):894–8.CrossRefGoogle Scholar
  5. 5.
    Ng VL, et al. Health status of children alive 10 years after pediatric liver transplantation performed in the US and Canada: report of the studies of pediatric liver transplantation experience. J Pediatr. 2012;160(5):820–6. e3CrossRefGoogle Scholar
  6. 6.
    Alonso EM, et al. Factors predicting health-related quality of life in pediatric liver transplant recipients in the functional outcomes group. Pediatr Transplant. 2013;17(7):605–11.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Sorensen LG, et al. Longitudinal study of cognitive and academic outcomes after pediatric liver transplantation. J Pediatr. 2014;165(1):65–72. e2CrossRefGoogle Scholar
  8. 8.
    Kaller T, et al. Cognitive abilities, behaviour and quality of life in children after liver transplantation. Pediatr Transplant. 2010;14(4):496–503.CrossRefGoogle Scholar
  9. 9.
    Kamath BM, et al. Consequences of JAG1 mutations. J Med Genet. 2003;40(12):891–5.CrossRefGoogle Scholar
  10. 10.
    Elisofon SA, et al. Health status of patients with Alagille syndrome. J Pediatr Gastroenterol Nutr. 2010;51(6):759–65.CrossRefGoogle Scholar
  11. 11.
    Kamath BM, et al. Quality of life and its determinants in a multicenter cohort of children with Alagille syndrome. J Pediatr. 2015;167(2):390–6. e3CrossRefGoogle Scholar
  12. 12.
    Kronsten V, Fitzpatrick E, Baker A. Management of cholestatic pruritus in paediatric patients with alagille syndrome: the King's college hospital experience. J Pediatr Gastroenterol Nutr. 2013;57(2):149–54.CrossRefGoogle Scholar
  13. 13.
    Mellion K, et al. Health-related quality of life outcomes in children and adolescents with congenital heart disease. J Pediatr. 2014;164(4):781–8. e1CrossRefGoogle Scholar
  14. 14.
    Al-Uzri A, et al. The impact of short stature on health-related quality of life in children with chronic kidney disease. J Pediatr. 2013;163(3):736–41. e1CrossRefGoogle Scholar
  15. 15.
    Emerick KM, et al. Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. Hepatology. 1999;29(3):822–9.CrossRefGoogle Scholar
  16. 16.
    Bales CB, et al. Pathologic lower extremity fractures in children with Alagille syndrome. J Pediatr Gastroenterol Nutr. 2010;51(1):66–70.CrossRefGoogle Scholar
  17. 17.
    Kamath BM, et al. Outcomes of liver transplantation for patients with Alagille syndrome: the studies of pediatric liver transplantation experience. Liver Transpl. 2012;18(8):940–8.CrossRefGoogle Scholar
  18. 18.
    Lykavieris P, et al. Outcome of liver disease in children with Alagille syndrome: a study of 163 patients. Gut. 2001;49(3):431–5.CrossRefGoogle Scholar
  19. 19.
    Leung DH, Sorensen LG, Ye W, Hawthorne K, et al. Neurocognitive status in Alagille Syndrome: Results of a Multi-Center Prospective Observational Study. Hepatology. 2017;66(S1):647–8.Google Scholar
  20. 20.
    Lee JM, et al. Delayed transplantation may affect intellectual ability in children. Pediatr Int. 2017;59(10):1080–6.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Ann & Robert H. Lurie Children’s Hospital of ChicagoChicagoUSA
  2. 2.Department of PediatricsNorthwestern University, Feinberg School of Medicine and The Ann & Robert H. Lurie Children’s Hospital of ChicagoChicagoUSA

Personalised recommendations